Allogeneic transplantation in adverse-risk acute myeloid leukemia: Challenges, strategies, and future directions

Chinese Journal of Cancer Research · Published 2025-01-01 · DOI 10.21147/j.issn.1000-9604.2025.05.05

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.21147/j.issn.1000-9604.2025.05.05

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Immune decoding from a multi-omics perspective: Redefining pancreatic cancer tumor microenvironment · Chinese Journal of Cancer Research · 2026 · Same journal
• Plasma cell-free DNA methylation markers for detection and prognosis of gastric cancer: A case-control study · Chinese Journal of Cancer Research · 2025 · Same journal
• Bridging transplantation and immunotherapy: Clinical promise of autologous stem cell transplantation with chimeric antigen receptor T-cell therapy · Chinese Journal of Cancer Research · 2025 · Same journal
• Spatial transcriptome revealed associated biomarkers for endocrine therapy response in HR-positive/HER2-negative early breast cancer · Chinese Journal of Cancer Research · 2026 · Same journal
• Breakthroughs in malignancy therapy: New advances and emerging trends in renal cell carcinoma · Chinese Journal of Cancer Research · 2026 · Same journal
• Turmoil and breakthroughs: Highlights and growing pains in breast cancer therapy 2025−2026 · Chinese Journal of Cancer Research · 2026 · Same journal
• Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer · Chinese Journal of Cancer Research · 2025 · Same journal
• Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: Targeting SLC25A1 to overcome immune resistance · Chinese Journal of Cancer Research · 2025 · Same journal
• Epidemiology, early detection, and management of breast cancer in China: A comprehensive review · Chinese Journal of Cancer Research · 2025 · Same journal
• Factors associated with neoadjuvant therapy insensitivity and its prognostic impact in HER2-positive breast cancer · Chinese Journal of Cancer Research · 2025 · Same journal